The Net Margin of Tarsus Pharmaceuticals Inc (TARS) is -63.16%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -63.16% |
2023-12-31 | -778.89% |
2022-12-31 | -240.47% |
2021-12-31 | -24.25% |